A researcher shall be honoured who has made significant scientific contributions in the fields of genome editing or gene therapy and whose work in the future can be expected to yield pathbreaking findings.
The award is endowed with 2.5 million euros. The sum to be awarded consists of a personal prize in the amount of 500,000 euros along with 2 million euros for the award-winner’s future research.
Nominations of younger scientists are particularly welcome. A decisive factor for receiving the award is the quality of the research project submitted.
An international jury of ten comprised of renowned researchers in the fields of genome editing and gene therapy together with representatives from the Scientific Commission at EKFS decides who shall receive the award.
From all nominations submitted, the jury chose shortlisted candidates at a joint session held on 10 July 2019. These candidates have now entered the final round and are allowed to submit a detailed full application regarding their respective research project.
The jury decision on the award recipient shall tentatively be made at the end of 2019.
Members of the Jury:
- Hildegard Büning, Hannover Medical School (Germany), jury chairwoman
- Michele Calos, Stanford University (USA)
- Nathalie Cartier, French Institute of Health and Medical Research, Paris (France)
- Stefan Endres, Ludwig-Maximilians-University Munich (Germany)
- Guangping Gao, University of Massachusetts (USA)
- Christine Klein, University of Lübeck (Germany)
- Luigi Naldini, San Raffaele Telethon Institute for Gene Therapy, Milan (Italy)
- Amit Nathwani, University College London (United Kingdom)
- Virginijus Siksnys, Vilnius University (Lithuania)
- Adrian Thrasher, University College London (United Kingdom)
You can obtain more information about the call for submissions for the Else Kröner Fresenius Prize for Medical Research here.